Kontratseptsiya i vozmozhnosti personifitsirovannogo podkhoda k ee naznacheniyu v razlichnye vozrastnye periody zhenshchiny


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Currently, hormonal contraception remains an important factor in maintaining the health of women from childhood to menopause. Age characteristics of the female body plays an important role in choosing the drugs for reliable, safe and acceptable prevention of unwanted pregnancies, and for the prevention of some of diseases, primarily disorders of reproductive system.

Texto integral

Acesso é fechado

Bibliografia

  1. Кулавский В.А., Даутова Л.А. Медико-социальные аспекты охраны репродуктивного здоровья / Мать и дитя: материалы IV Рос. Форума. М., 2002. Ч. 1. С. 50-52.
  2. Коновалов В.А., Курников В.С. Медико-социальные аспекты проблемы регулирования рождаемости в современных условиях / Мать и дитя: материалы IV Рос. Форума. М., 2002.Ч. 1. С. 43-44.
  3. Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция. М., 2011. C. 156-58.
  4. Ромащенко О.В. История развития женской сексологии. Медицинские аспекты здоровья женщины. 2007;3:14-16.
  5. Calaf I., Alsina J. After 50 years of ethinylestradiol, anotheroestrogen in combined oral contraceptives. Eur. J. Contracept. Reprod. Health Care. 2010;15:1-3.
  6. Dore D.D., Norman H., Loughlin J., et al. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception. 2010;81(5):408-13.
  7. Dhont M. History of oral contraception. Eur. J. Contracept. Reprod. Health Care. 2010;15(2):12-8.
  8. Hannaford P.C., Iversen L., Macfarlane T.V., et al. Mortality among contraceptive pill users: Cohort evidence from RoyalCollege of General Practitioners'Oral Contraception Study. BMJ. 2010;340:927. doi: 10.1136/bmj.c927.
  9. Kiley J., Hammond C. Combined oral contraceptives: A comprehensive review. Clin. Obstet. Gynecol. 2007;50:868-77.
  10. Lete I., et al. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011;154(1):71-80.
  11. Nelson H.D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA. 2004;291(13):1610-20.
  12. Tariq N., et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J. Coll. Physicians. Surg. Pak. 2011;21(4):210-13.
  13. Armstrong, C. ACOG Guidelines on Noncontraceptive Uses of Hormonal Contraceptives. Am. Fam. Phys. 2010;82(3):294-95.
  14. Michael F. Costello1, Bhushan Shrestha, John Eden, Neil P. Johnson and Peter Sjoblom. Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Human Reproduction. 2007; 22(5):1200-09.
  15. Noncontraceptive Uses of Hormonal Contraceptives. Practice Bulletin No. 110. Obstet. Gynecol. 2010;115(11):206-18.
  16. Wong C.L., Farquhar C., Roberts H., Proctor M. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhea. Published Online. October 7, 2009.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2014

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies